Clinical Trial Update: The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for Zishenqing in active systemic lupus erythematosus across Phase 2 and Phase 3 phases; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Zishenqing

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Systemic Lupus Erythematosus | Phase 2, Phase 3 | Status: UNKNOWN